國際肽研究與治療雜志發(fā)表肽治療學和高質(zhì)量研究的最新進展，涵蓋肽科學的各個方面。該雜志匯集了肽研究領域最令人興奮的同行評審工作，包括肽的分離、結構表征、合成和生物活性，從而有助于從不同角度發(fā)展統(tǒng)一的概念。報道包括肽藥物傳遞系統(tǒng)的新進展;肽治療在特定疾病中的應用合成方法的進展;建立肽庫的新程序和篩選這種混合物的方法的發(fā)展;多肽在酶的特異性及其機制、受體結合和抗體/抗原相互作用研究中的應用色譜、電泳、核磁共振、x射線晶體學等技術的應用質(zhì)譜分析。IJPRT要求所有作者遵守施普林格的倫理政策。這些倫理聲明應該在所有3篇倫理聲明的所有文章以及所有提到的作者的名字上清楚地標明。這些語句應該放在每篇文章的末尾參考部分之前。

The International Journal of Peptide Research and Therapeutics publishes the latest developments in peptide therapeutics and high quality research covering all aspects of peptide science. The journal brings together in a single source the most exciting peer-reviewed work in peptide research, including isolation, structural characterization, synthesis and biological activity of peptides, and thereby aids in the development of unifying concepts from diverse perspectives.Coverage includes new advances in peptide drug delivery systems; application of peptide therapeutics to specific diseases; advances in synthetic methods; development of new procedures for construction of peptide libraries and methodology for screening of such mixtures; the use of peptides in the study of enzyme specificity and mechanism, receptor binding and antibody/antigen interactions; applications of such techniques as chromatography, electrophoresis, NMR and X-ray crystallography; mass spectrometry.IJPRT requests that all authors comply to Springer’s ethical policies. These ethical statements should be clearly indicated on all articles for all 3 ethics statements and for all authors mentioned by name. These statements should be placed at the end of each article just before the Reference section.